$USAC

USA Compression Partners (USAC) On Its $600 Million Notes Deal And Valuation Question

USA Compression Partners (USAC) announced a $600 million senior unsecured notes offering due 2035 and plans to move its listing from the NYSE to the Texas Stock Exchange. The company's share price is $27.64, with a year-to-date return of 16.18% and a 1-year total shareholder return of 24.52%. Analysts have a price target of $27.64, and the company is trading at a P/E ratio of 27.8x, above the industry average of 26.1x.

Original reporting
Published Sep 13, 2026, 10:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 7:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$USAC
Bearish
high confidence
Mentioned
$USAC
Relevance
8/10
AlphAI data visualization · based on simplywall.st
Decision brief

The 30-second read

$USACBearishHigh
01

Why it matters

The new debt issuance and exchange migration introduce both financing risk and possible liquidity benefits, influencing valuation metrics.

02

Market read

The announcement is a material corporate financing event for a mid‑cap energy services company, likely to affect its stock price and sector peers.

03

What to watch

Potential tax or regulatory benefits from the Texas exchange listing and the terms of the notes (coupon, covenants) are not disclosed.

Relevance 8/10Novelty 8/10Timing: recently announced

Background

USA Compression Partners provides natural gas compression services and has delivered strong total shareholder returns, but faces concentration risk with a few large customers.

Company-level read

Ticker impact

$USACBearishHigh confidence
Context

USA Compression Partners announced a $600 million senior unsecured notes offering due 2035 and plans to move its listing to the Texas Stock Exchange.

Expected impact

Potential short‑term downside as investors price in higher debt load; long‑term upside if the new listing improves trading dynamics.

Evidence & confidence

A $600 M capital raise is material for a mid‑cap energy services firm; market typically reacts to new debt issuance and listing changes.

Market effects

May signal increased financing activity in the energy services sector, prompting peers to reassess capital structures.

The Texas Stock Exchange move could attract regional investors and affect trading volumes in the U.S. mid‑cap space.

Limited to U.S. energy services; unlikely to drive broader market moves.

Counterpoint

If the capital raise funds growth projects that boost cash flow, the stock could rally despite higher leverage.

Key entities

  • USA Compression Partners

    Energy services firm issuing $600 M senior notes and moving to the Texas Stock Exchange.

Related articles

$ETMed

Texas Stock Exchange captures first primary equity market listings from NYSE

The Texas Stock Exchange (TXSE) secured its first primary equity listings, with Energy Transfer, USA Compression Partners, Sunoco LP, and SunocoCorp LLC moving from the NYSE. The companies have a combined market cap of nearly $100 billion. TXSE aims to challenge NYSE and Nasdaq by leveraging Texas's business-friendly policies, though analysts note past attempts faced challenges.

$ETLow

NYSE Loses First Major Listing as $100bn Moves to the Texas Stock Exchange

Energy Transfer and three affiliates (ET, SUN, SUNC, USAC) plan to move their primary listings from the NYSE to the Texas Stock Exchange (TXSE), representing nearly $100 billion in market value. The move, effective in early October, marks the first major listing loss for the NYSE. TXSE, backed by major firms, aims to attract more listings and has updated index eligibility rules to facilitate the transition.

$USACMed

United States Antimony Corporation Q2 2026 Earnings Call Summary

United States Antimony Corp. reported Q2 2026 revenue down 25% year over year, driven mainly by a 52% fall in realized antimony prices. The company is building $21.6M inventory for its sole-source DLA contract and raised zeolite segment revenue 110%. Full-year 2026 revenue guidance was cut to $60-$75M due to lower pricing; it has $62.2M cash plus a $43.2M Larvotto equity stake.

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or

$PHOSMed

First Phosphate shareholders could see reduced dilution risk, Noble says after SERV news

First Phosphate Corp. (PHOS) may face reduced equity dilution after Noble Capital Markets noted potential lower funding needs for its Bégin-Lamarche project, supported by Swiss Export Risk Insurance (SERV) and other financing. SERV could provide up to US$212.5 million, reducing the equity requirement to about US$82.5 million. Noble maintains an Outperform rating and $25.50 price target.